InMode Ltd. (INMD)Healthcare | Medical Devices | Yokne'am, Israel | NasdaqGS
15.15 USD
-0.13
(-0.851%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 15.15 |
Hot Take ↕ | July 11, 2026, 3:01 a.m. EDT
The investment case for InMode is currently paralyzed by a disconnect between its pristine balance sheet and its deteriorating market performance. Fundamentally, the company holds a fortress-like balance sheet with negligible debt and massive liquidity, yet it is trading at a discount to book value while reporting negative earnings growth and a trailing 12-month loss. This creates a classic value trap scenario where the market has priced in a structural decline despite the company's operational efficiency. The price history confirms this pessimism: after a massive spike in 2021, the stock has been in a secular downtrend, dropping nearly 60% in 2022 and continuing to bleed value in 2024 and 2025. Although the most recent quarter showed a modest 5% revenue recovery, the momentum remains broken, with two consecutive years of negative annual returns. The recent news of an unsolicited buyout proposal adds a layer of uncertainty; while insiders are pushing for a deal, the lack of a definitive agreement and the presence of dissenting shareholders suggest the exit strategy is not guaranteed. Options activity reinforces this defensive posture. Traders are buying significant downside protection, betting on further weakness, while call buyers remain cautious. With no dividend to provide income and a statistical forecast showing a slight negative bias over the next month, there is no immediate catalyst to drive a reversal. Until the earnings growth turns consistently positive or a buyout closes, the risk-reward profile remains skewed against the buyer. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.042872 |
| AutoETS | 0.042946 |
| AutoARIMA | 0.042953 |
| MSTL | 0.043709 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 48% |
| H-stat | 1.40 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.115 |
| Excess Kurtosis | -0.66 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.73 |
| Revenue per Share | 5.919 |
| Market Cap | 870,833,664 |
| Trailing P/E | 11.22 |
| Forward P/E | 10.46 |
| Beta | 1.91 |
| Profit Margins | 23.27% |
| Website | https://www.inmodemd.com |
As of July 11, 2026, 3:01 a.m. EDT: Speculators are positioning defensively with heavy out-of-the-money put volume at strikes below the current price, particularly for the August and November expirations, suggesting a fear of a downside gap or continued weakness. Conversely, call interest is concentrated at the money and slightly out-of-the-money, indicating a belief that the stock will consolidate near current levels rather than surge significantly. The skew suggests a 'wait and see' approach where downside protection is prioritized over aggressive upside speculation.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.03663504 |
| Address1 | Tavor Building |
| Address2 | Sha’ar Yokneam PO Box 533 |
| All Time High | 99.27 |
| All Time Low | 6.53 |
| Ask | 19.4 |
| Ask Size | 2 |
| Average Analyst Rating | 3.0 - Hold |
| Average Daily Volume10 Day | 761,750 |
| Average Daily Volume3 Month | 834,895 |
| Average Volume | 834,895 |
| Average Volume10Days | 761,750 |
| Beta | 1.912 |
| Bid | 10.95 |
| Bid Size | 2 |
| Book Value | 10.783 |
| City | Yokne'am |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 15.15 |
| Current Ratio | 8.801 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 15.285 |
| Day Low | 15.0794 |
| Debt To Equity | 0.73 |
| Display Name | InMode |
| Earnings Call Timestamp End | 1,778,070,600 |
| Earnings Call Timestamp Start | 1,778,070,600 |
| Earnings Growth | -0.308 |
| Earnings Quarterly Growth | -0.365 |
| Earnings Timestamp | 1,785,933,000 |
| Earnings Timestamp End | 1,785,933,000 |
| Earnings Timestamp Start | 1,785,933,000 |
| Ebitda | 80,521,000 |
| Ebitda Margins | 0.21493 |
| Enterprise To Ebitda | 5.318 |
| Enterprise To Revenue | 1.143 |
| Enterprise Value | 428,195,136 |
| Eps Current Year | 1.322 |
| Eps Forward | 1.448 |
| Eps Trailing Twelve Months | 1.35 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 14.0084 |
| Fifty Day Average Change | 1.1415997 |
| Fifty Day Average Change Percent | 0.08149394 |
| Fifty Two Week Change Percent | 3.6635041 |
| Fifty Two Week High | 16.74 |
| Fifty Two Week High Change | -1.5900002 |
| Fifty Two Week High Change Percent | -0.09498209 |
| Fifty Two Week Low | 12.72 |
| Fifty Two Week Low Change | 2.4299994 |
| Fifty Two Week Low Change Percent | 0.19103768 |
| Fifty Two Week Range | 12.72 - 16.74 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,565,271,000,000 |
| Float Shares | 53,888,948 |
| Forward Eps | 1.448 |
| Forward P E | 10.4627075 |
| Free Cashflow | 43,626,624 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 660 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.77838 |
| Gross Profits | 291,611,008 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.13141 |
| Held Percent Institutions | 0.59243 |
| Implied Shares Outstanding | 57,480,772 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,633,046,400 |
| Last Split Factor | 2:1 |
| Long Business Summary | InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. In addition, it offers hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. The company was incorporated in 2008 and is headquartered in Yokne'am, Israel. |
| Long Name | InMode Ltd. |
| Market | us_market |
| Market Cap | 870,833,664 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_100060854 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | 87,192,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 878,881,003 |
| Number Of Analyst Opinions | 3 |
| Open | 15.2 |
| Operating Cashflow | 86,599,000 |
| Operating Margins | 0.122609995 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.83 |
| Phone | 972 4 909 6313 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 15.15 |
| Post Market Time | 1,783,973,404 |
| Previous Close | 15.28 |
| Price Eps Current Year | 11.4599085 |
| Price Hint | 2 |
| Price To Book | 1.4049892 |
| Price To Sales Trailing12 Months | 2.324467 |
| Profit Margins | 0.23274 |
| Quick Ratio | 7.47 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 3.0 |
| Region | US |
| Regular Market Change | -0.13 |
| Regular Market Change Percent | -0.850786 |
| Regular Market Day High | 15.285 |
| Regular Market Day Low | 15.0794 |
| Regular Market Day Range | 15.0794 - 15.285 |
| Regular Market Open | 15.2 |
| Regular Market Previous Close | 15.28 |
| Regular Market Price | 15.15 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 693,078 |
| Return On Assets | 0.06855 |
| Return On Equity | 0.13617 |
| Revenue Growth | 0.053 |
| Revenue Per Share | 5.919 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 57,480,772 |
| Shares Percent Shares Out | 0.0512 |
| Shares Short | 2,943,231 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 2,859,868 |
| Short Name | InMode Ltd. |
| Short Percent Of Float | 0.058000002 |
| Short Ratio | 3.75 |
| Source Interval | 15 |
| Symbol | INMD |
| Target High Price | 15.0 |
| Target Low Price | 14.0 |
| Target Mean Price | 14.33333 |
| Target Median Price | 14.0 |
| Total Cash | 537,158,976 |
| Total Cash Per Share | 8.472 |
| Total Debt | 4,829,000 |
| Total Revenue | 374,638,016 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 1.35 |
| Trailing P E | 11.222221 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 14.34815 |
| Two Hundred Day Average Change | 0.80184937 |
| Two Hundred Day Average Change Percent | 0.055885207 |
| Type Disp | Equity |
| Volume | 693,078 |
| Website | https://www.inmodemd.com |
| Zip | 2,069,206 |